NY/NJ CEO
Date: Location: Cost:
November 7 - 8, 2017 Apella at Alexandria Center
450 E. 29 Street
New York, NY 10016
(212) 706-4100
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

Conference Details

NY/NJ CEO is an off-the-record networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from keynotes, fireside chats, and discussion panels featuring CEOs from several of the world's leading biopharmaceutical companies. Healthcare investors also attend.

Testimonials:

“NY/NJ CEO is one of the best curated meetings I attend. It’s a premier opportunity to learn and to network with leaders in one of the most rapidly growing biotech hubs in the country.” -- Ron Cohen, President and CEO, Acorda Therapeutics

“This meeting provides a valuable and unique forum to debate market trends and connect with other senior leaders across the biopharma industry in an off-the-record environment.” -- Francois Nader, Chairman, Acceleron Pharma

Speakers and Co-hosts include: Ron CohenPresident & CEO, Acorda; Ron Cooper, President & CEO, Albireo Pharma; Luigi Costa, President & CEO, Nordic Nanovector; Anil Diwan, President & Chairman, NanoViricides; Mikael Dolsten, President, WWRD, Pfizer; Carl Firth, CEO, Aslan Pharmaceuticals; Carl Gordon, General Partner, OrbiMed; Glenn Gormley, Executive Chairman & President, Daiichi Sankyo; Charlotte Hubbert, Partner, Gates Foundation Venture Capital; Matthew Kane, CEO, Precision Biosciences; Glenn Kazo, CEO, Prolong Pharmaceuticals; Ramesh Kumar, President & CEO, Onconova; Jonathan Lewis, Chairman & CEO, Samus Therapeutics; William Lewis, President & CEO, Insmed Jimmy Lin, CSO, Natera; Thomas Lonngren, Former Director, EMA; Philippe Lopes-Fernandes, SVP, Global Head, BD, EMD Serono; Brian McVeigh, VP, WWBD Transactions, GlaxoSmithKline; Francois Nader, Chairman, Acceleron; Joseph Payne, President & CEO, Arcturus; Jonathan Peacock, Chairman, Arix Bioscience; Cynthia Schwalm, EVP & President, North American Commercial Operations, IPSEN; Bob Silverman, Head, Externalized Drug Discovery Partnering, Roche; Steve Tregay, CEO, FORMA Therapeutics; Gregory Verdine, Founder, CEO, & CSO, Fog Pharmaceuticals; Harlan Waksal, President & CEO, Kadmon; James Sapirstein, CEO, Contravir Pharmaceuticals; James Sapirstein, CEO, Contravir Pharmaceuticals; Rahul Kakkar, Founder & EVP Clinical and Strategic Development, Cordivia; George Yancopoulos, President & CSO, Regeneron Pharmaceuticals

Premier Sponsors: (see all sponsors)